Table 1 Differential frequency of Lymphocytes and serum levels of immunoglobulins in the patient
From: Graft versus host disease and microchimerism in a JAK3 deficient patient
Parameters | Patient | Normal rangea |
|---|---|---|
WCB (cell*103/µL) | 10.3b | 5–17 |
Eosinophils % (count, cell/mL) | 8.2 (851)b | 0–1 |
Platelets, count, cells*109/L | 325b | 150–400 |
Hemoglobin, g/dL | 10.4b | 11.5–14.0 |
Lymphocyte % (count, cell/mL) | 78.7 (8169)b | 50–70 |
CD3% (count, cell/mL) | 93.5 (7643)b | 56–75 |
CD4% (count, cell/mL) | 86.4 (7063)b | 28–47 |
CD4+ CD45RA+ CD45RO− (naïve) % of helper T cells | 59 | 11–53 |
CD4+ CD45RA-CD45RO+ (memory) % of helper T cells | 28 | 31–74 |
CD4+ HLA-DR+ CD38− (activated) % of helper T cells | 3 | 2–11 |
CD8% (count, cell/mL) | 4.6 (382)b | 16–30 |
CD8+ CD45RA+ CD45RO− (naïve) % of cytotoxic T cells | 75 | 27–69 |
CD8+ CD45RA-CD45RO+ (memory) % of cytotoxic T cells | 15 | 12–50 |
CD8+ HLA-DR+ CD38− (activated) % of % of cytotoxic T cells | 2 | 2–22 |
CD16% (count, cell/mL) | 4.2 (343.1)b | 4–17 |
CD19% (count, cell/mL) | 4.05 (331)b | 14–33 |
Lymphocyte proliferation responses to PHA | 1.5 | > 0.3 |
Quantitative CD4+ PHA response (c/µL) | 120b | 170–3499 |
Quantitative CD8+ PHA response (c/µL) | 25b | 76–3640 |
IgG (mg/dL) | 332b | 295–1156 |
IgA (mg/dL) | 5b | 27–246 |
IgM (mg/dL) | 87b | 37–184 |
Anti-tetanus (IU/mL) | 0.05b | > 0.1 |
Anti-diphtheria (IU/mL) | 0.01b | > 0.1 |
TRECs | 10c | 23–67 |